NewsResearchTreatment IASLC Targeted Therapies Recap #TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…rdsupportMarch 11, 2024
NewsTreatment RET inhibitor Granted Fast Track by FDA Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by FDA Ellipses Pharma…rdsupportMarch 11, 2024
NewsNino's NewsResearchTreatment Looking Ahead: The Future of Diagnostic Testing for Patients Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…rdsupportJanuary 7, 2024
NewsResearchTreatment 2023 RET Cancer Research Update 2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…rdsupportDecember 18, 2023
NewsResearchTreatment Exciting Preclinical Results About Vepafestinib New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06). Vepafestinib showed selectivity…rdsupportOctober 10, 2023
Clinical TrialsNewsResearchTreatment New clinical trial testing amivantamab New clinical trial testing amivantamab for patients who progressed on RET therapies: A Phase 1…rdsupportOctober 8, 2023
Biomarker TestingNewsNino's NewsResourcesTreatment Finding the Right Time to Ask About Biomarker Testing Increasingly, cancer care is being approached with precision medicine methods that can offer personalized medical…rdsupportJuly 27, 2023
NewsResearchTreatment Two research studies funded by HLP presented at 2023 ASCO Mtg Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…rdsupportJune 19, 2023
NewsResearchTreatment Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…rdsupportJune 19, 2023
EducationNewsResearchResourcesTreatment DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…rdsupportJune 19, 2023